Press Releases

  • Georgetown Medical Experts Available During Olympic Games
    August 5, 2016

    WASHINGTON -– Georgetown University Medical Center physicians and researchers are available to answer questions about medical topics related to athletes competing in the 2016 Olympic Games.

    Learn More
  • Collateral Harm: The Impact of Ebola and Related Fears on Facility-Based Child Deliveries
    August 2, 2016

    WASHINGTON -- The first known household survey examining the collateral harm to pregnancy services in areas affected by the West African Ebola epidemic suggests a significant slide backwards in child and maternal health. The study, conducted in Liberia, points to the deep disruptions caused by the Ebola epidemic — even in parts of the country with relatively limited transmission.

    Learn More
  • Switch from Observation Only to Active Treatment by Patients with Prostate Cancer Varies by Race and Ethnicity
    July 29, 2016

    NEW YORK, NY -- Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study published in The Journal of Urology.

    Learn More
  • Zika Has Arrived, But is the U.S. Ready?
    July 29, 2016

    WASHINGTON –The Florida Department of Health, investigating non-travel related cases of Zika in Miami-Dade and Broward counties, has concluded “that a high likelihood exists that four cases are the result of local transmission.” Despite the advance warning of Zika’s approach, Georgetown experts in infectious disease, public health law, health systems readiness and mosquito research say the United States isn’t ready for a Zika outbreak. 

    Learn More
  • More Evidence in Quest to Repurpose Cancer Drugs for Alzheimer’s Disease
    July 27, 2016

    TORONTO – An FDA approved drug to treat renal cell carcinoma appears to reduce levels of a toxic brain protein linked to dementia in Alzheimer’s and Parkinson’s diseases when given to animals. This finding is the latest from Georgetown University Medical Center’s Translational Neurotherapeutics Program (TNP) examining tyrosine kinase inhibitors in the treatment of neurodegenerative diseases.

    Learn More
  • Resveratrol Appears to Restore Blood-Brain Barrier Integrity in Alzheimer’s Disease
    July 27, 2016

    TORONTO — Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers at Georgetown University Medical Center. The reduction in neuronal inflammation slowed the cognitive decline of patients, compared to a matching group of placebo-treated patients with the disorder.

    Learn More
  • Georgetown Lombardi
    Public Health Benefits of E-cigarette Use Tend to Outweigh the Harms
    July 14, 2016

    A modeling study by top tobacco control experts finds that e-cigarettes are likely to provide public health benefits based on “conservative estimates” of the likely uptake of vaping and smoking by adolescents and young adults.

    Learn More
  • NEJM: “TBI’s Long-Term Follow-up — Slow Progress in Science and Recovery”
    July 13, 2016

    WASHINGTON – Eleven years ago in the New England Journal of Medicine, medical journalist Susan Okie, MD, first introduced readers to two U.S. Army veterans who suffered traumatic brain injuries in Iraq, and the challenges they faced in the recovery period after returning home. In the July 14 issue of the NEJM, Okie describes her follow-up interviews with the soldiers, and the slow journey to recovery that continues more than a decade later.

    Learn More
  • Study: Cancer Drug Restores Brain Dopamine, Reduces Toxic Proteins in Parkinson, Dementia
    July 11, 2016

    WASHINGTON — A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies. Dopamine is the brain chemical (neurotransmitter) lost as a result of death of dopamine-producing neurons in these neurodegenerative diseases.

    Learn More
  • Zika Virus - Subject Matter Experts
    July 8, 2016

    Zika virus information continues to flow from various countries’ health ministries and other sources. Georgetown University professors are paying special attention to this global health threat and are available to provide context and expert comment.

    Learn More